NPPB and End Stage Liver Disease: Accordingly, our data confirm the hypothesis already reported by Henriksen et al [12], that NT pro-BNP levels could be a marker of cardiovascular diastolic dysfunction in patients with end stage liver disease, acting as mediator of splanchnic vasodilatation in liver cirrhosis [8], [9].